Tiziana Life Sciences Ltd
TLSA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $92,293 | $37,983 | $45,652 | $28,745 |
| - Cash | $7,251 | $3,724 | $1,130 | $1,183 |
| + Debt | $107 | $106 | $179 | $247 |
| Enterprise Value | $85,149 | $34,365 | $44,701 | $27,809 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$88 | -$61 | -$126 | -$41 |
| % Margin | – | – | – | – |
| EBITDA | -$5,544 | -$8,699 | -$15,834 | -$8,579 |
| % Margin | – | – | – | – |
| Net Income | -$5,632 | -$7,209 | -$9,308 | -$9,074 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.096 | -0.13 | -0.18 | -0.18 |
| % Growth | 25.8% | 27.8% | 0% | – |
| Operating Cash Flow | -$6,823 | -$1,539 | $316 | -$3,408 |
| Capital Expenditures | -$6 | -$4 | -$11 | $0 |
| Free Cash Flow | -$6,829 | -$1,543 | $305 | -$3,408 |